在癌症中探索光纤的治疗潜力
Gabriella Cancemi1, Santino Caserta1, Sebastiano Gangemi2
1Hematology Unit, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, via Consolare Valeria, 98125 Messina, Italy.
Journal of clinical medicine
|February 24, 2024
概括
药用真菌Ganoderma lucidum含有诸如甘酸之类的化合物,它们对血液恶性瘤具有抗癌作用. 它的化合物诱导细胞亡和免疫反应,表明潜在的临床应用.
科学领域:
- 菌类学 菌类学是指菌类学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 甘菌 (Ganoderma lucidum) 是一种富含三烯酸和多糖的药用真菌.
- 甘酸是一种关键化合物,表现出各种抗癌机制.
- 现有的研究表明,在血液性恶性瘤中具有潜在的治疗作用.
研究的目的:
- 审查Ganoderma lucidum化合物的治疗潜力,以对抗血液性恶性瘤.
- 阐明甘光在癌症治疗中的作用机制.
- 评估将Ganoderma lucidum纳入血液癌症临床实践的可行性.
主要方法:
- 综述现有的关于甘光及其对癌细胞的影响的文献.
- 分析详细介绍甘酸和其他化合物的分子机制的研究.
- 对研究抗增殖和免疫调节作用的体外和体内研究的评估.
主要成果:
- 甘酸表现出对白血病,淋巴瘤和髓瘤细胞系的抗增殖活性.
- 光的化合物诱导了细胞亡,线粒体损伤和免疫系统刺激.
- 在体内研究显示,白血病小鼠的免疫细胞活性和前体分化增强.
结论:
- 光 (Ganoderma lucidum) 在治疗血液性恶性瘤方面具有显著的潜力.
- 它的化合物具有针对性的抗癌作用,对正常细胞的毒性最小.
- 需要进一步的临床研究,以将Ganoderma lucidum纳入癌症治疗中.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

